Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03576131 |
| Title | GEN1029 (HexaBody-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Genmab |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | GBR | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale University | New Haven | Connecticut | 06510 | United States | Details | |
| UT M.D Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Hospital Univeritario Vall d'Hebron | Barcelona | Spain | Details | |||
| START Madrid CIOCC | Madrid | Spain | Details | |||
| The Newcastle upon Tyne Hospitals NHS Foundation Trust | Newcastle | United Kingdom | Details | |||
| The Royal Mardsen NHS Foundation Trust | Sutton | United Kingdom | Details |